ThursdayOct 22, 2026 9:00 am

Nano-X Imaging Ltd. (NASDAQ: NNOX) Advances Its Mission to Expand Access to Medical Imaging

Nanox is working to make advanced medical imaging more accessible through digital 3D tomosynthesis technology designed to enhance visualization beyond conventional X-rays. Its Nanox.ARC platform combines imaging hardware with cloud-based infrastructure, while the company’s broader services support image interpretation and clinical workflows. By connecting image acquisition with remote radiology expertise and AI-powered analysis, Nanox aims to support healthcare providers’ imaging and interpretation workflows more efficiently. Access to medical imaging remains an important consideration for healthcare systems, particularly in underserved regions where equipment, infrastructure and trained personnel may be limited. While conventional X-rays play an essential role in diagnostic care, their…

Continue Reading

FridayOct 16, 2026 3:40 pm

QualityStocksNewsBreaks – Nano-X Imaging Ltd. (NASDAQ: NNOX) Highlights Insider Buying Alongside Its Integrated Healthcare Technology Strategy

Recent SEC Form 4 filings disclosed open-market purchases of Nano-X Imaging Ltd.’s (NASDAQ: NNOX) (“Nanox”) ordinary shares by CEO Erez Meltzer and Board Director Dan Suesskind, adding to purchases reported in recent months by Meltzer, Suesskind and Board Director Nogah Keinan. The transactions reflect share purchases made directly in the open market by the company’s senior leadership and board members, with additional details available in the respective SEC filings. This comes as Nanox continues to advance its integrated medical imaging and healthcare services platform, which combines proprietary digital X-ray technology, AI-powered imaging analytics, cloud-based software, remote radiology services and healthcare…

Continue Reading

WednesdayOct 14, 2026 2:37 pm

QualityStocksNewsBreaks – Nano-X Imaging Ltd. (NASDAQ: NNOX) Strengthens UK Market Access and Hospital-Based AI Capabilities

Nano-X Imaging Ltd. (NASDAQ: NNOX) (“Nanox”), an innovative technology company, is advancing Nanox.AI’s commercial and technology strategy through two developments aimed at expanding the use of AI in medical imaging. An exclusive three-year reseller agreement with Vertec Scientific, including minimum annual license commitments, establishes a dedicated UK channel for HealthOST, an AI-powered software solution that delivers qualitative and quantitative analysis of spinal CT images to help clinicians evaluate and assess spinal musculoskeletal disease, including osteoporosis. Separately, Nanox.AI has optimized its imaging AI framework for Intel Core Ultra processors using OpenVINO, demonstrating the potential to run AI inference locally on hospital…

Continue Reading

WednesdaySep 30, 2026 12:00 pm

Nano-X Imaging CEO and Directors Report Open-Market Share Purchases

Nano-X Imaging Ltd. (NASDAQ: NNOX) today announced that recent SEC Form 4 filings disclosed open-market purchases of the company's ordinary shares by Chief Executive Officer Erez Meltzer and Board Director Dan Suesskind. These purchases are in addition to other open-market purchases of Nano-X ordinary shares by company insiders including Erez Meltzer, Dan Suesskind and Board Director Nogah Keinan reported in recent months. Together, the purchases represent Nano-X ordinary shares acquired in the open market by the company's CEO and members of its Board of Directors. Additional information regarding the transactions is available in the respective SEC filings. About Nanox  Nanox…

Continue Reading

TuesdaySep 29, 2026 10:30 am

Finding What the Scan Already Captured: Nanox Advances Its AI Business on Two Fronts

Approximately 86,000 vertebral fragility fractures occur annually in the UK, with most remaining undiagnosed. Nanox.AI has signed an exclusive three-year UK reseller agreement with Vertec Scientific for its HealthOST bone solution, with minimum annual license commitments built into the deal. A separate optimization project with Intel demonstrates a path for Nanox.AI's imaging AI framework to run inference locally on hospital hardware rather than relying entirely on the cloud. A CT scan ordered to answer one clinical question may capture additional anatomical information beyond the original indication. In certain cases, routine CT imaging can include information related to the spine, coronary…

Continue Reading

FridaySep 25, 2026 9:45 am

Nanox’s Integrated Imaging Ecosystem: Expanding Access to 3D Imaging and Diagnostics

Roughly two-thirds of the world's population lacks access to basic imaging technology, and the radiologist workforce gap is just as stark. Nanox brings together Nanox.ARC, Nanox.AI, Nanox.CLOUD, Nanox.MARKETPLACE, USARAD Holdings and Nanox Health IT as part of its broader imaging ecosystem. Commercial activity is beginning to build, with second-quarter revenue of $4.2 million. Advanced medical imaging has transformed diagnosis, yet access to it remains remarkably uneven. Roughly two-thirds of the world's population lacks access to basic imaging technology, a figure widely attributed to the World Health Organization, and the workforce gap is just as stark: an estimated 1.9 radiologists per…

Continue Reading

FridaySep 18, 2026 3:04 pm

QualityStocksNewsBreaks – Nano-X Imaging Ltd. (NASDAQ: NNOX) Is Building End-to-End Platform for the Future of Medical Imaging

Nanox (NASDAQ: NNOX) is positioning itself as an integrated medical imaging and healthcare technology company, combining proprietary digital X-ray hardware, FDA-cleared AI applications, cloud software, teleradiology, and healthcare IT into an end-to-end platform designed to support earlier disease detection and more efficient care. Its ecosystem includes Nanox.ARC and the next-generation Nanox.ARC X imaging systems, Nanox.AI algorithms for identifying potential signs of chronic disease, Nanox.CLOUD for imaging management, and services through USARAD, Nanox.MARKETPLACE and Nanox Health IT. The company is expanding commercial and clinical activity through relationships with organizations including RadNet, Cedars-Sinai, Corewell Health and Brigham and Women’s Hospital, while also…

Continue Reading

FridaySep 04, 2026 10:10 am

QualityStocksNewsBreaks – Nanox Imaging Ltd. (NASDAQ: NNOX) Expands Nanox.ARC Distribution in New England

Nanox (NASDAQ: NNOX), through its U.S.-based subsidiary Nanox Impact Inc., entered into a distribution agreement with Associated X-Ray Imaging Corp. to support deployment of the Nanox.ARC across New England. Under the agreement, Associated X-Ray Imaging will market, distribute and support the FDA-cleared, multisource 3D digital tomosynthesis system, leveraging its regional customer relationships and service infrastructure. The agreement expands Nanox’s U.S. channel partner network and is intended to increase access to the Nanox.ARC in outpatient and community-based clinical settings across targeted markets. To view the full press release, visit https://ibn.fm/ChGtd About Nanox Nanox (NASDAQ: NNOX) is focused on driving the world’s…

Continue Reading

WednesdayAug 26, 2026 9:00 am

QualityStocksNewsBreaks – Nanox Imaging Ltd. (NASDAQ: NNOX) to Report Second-Quarter 2026 Financial Results Sept. 9

Nanox (NASDAQ: NNOX), an innovative medical imaging technology company, announced it will report financial results for the quarter ended June 30, 2026, before market open on Sept. 9, 2026. CEO and Acting Chairman Erez Meltzer and CFO Guy Nathanzon will host a conference call beginning at 8:30 a.m. ET to review the results and provide a business update. A live webcast will also be available through the Investor Relations section of the Nanox website. To view the full press release, visit https://ibn.fm/y877D About Nanox Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering…

Continue Reading

TuesdayAug 25, 2026 9:00 am

Nano-X Imaging Ltd. (NASDAQ: NNOX) Is ‘One to Watch’

The company combines proprietary imaging hardware, FDA-cleared AI applications, cloud software, radiology services and healthcare IT within an end-to-end platform spanning scan, analysis and interpretation. Nanox is expanding its commercial reach through its U.S. commercial activities and collaboration with healthcare organizations. First-quarter 2026 revenue increased to $4.3 million from $2.8 million in the prior-year period, with contributions from teleradiology, imaging systems, OEM services, AI, software and Health IT. Nanox has secured FDA clearance for Nanox.ARC, Nanox.ARC X and three Nanox.AI medical imaging solutions, while its commercial and clinical activities involve organizations including RadNet, Cedars-Sinai, Corewell Health and Brigham and Women’s…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered